UPDATE 1-AstraZeneca sells British R&D site, to take $275 mln charge
March 12, 2014 at 05:41 AM EDT
LONDON, March 12 (Reuters) - AstraZeneca has agreed to sell its Alderley Park research site in northern England to a public-private partnership group as it moves drug discovery to a new global centre in Cambridge.
